{"entity":{"type":"insider","cik":"0001433982","url":"/insider/0001433982","json_url":"/insider/0001433982.json","name":"ZELDIS JEROME B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":21,"first":"2013-02-25","last":"2024-12-04","span_basis":"filed_date"},"name_variants":[{"name":"ZELDIS JEROME B","source":"filing","n_filings":21,"first_seen":"2013-02-25","last_seen":"2024-12-04"}],"transactions":[{"id":2191315,"accession":"0001415889-24-028287","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-028287","line_url":"/filing/0001415889-24-028287","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":51.49572875,"price_display":"51.50","price_state":"stated","total_value":1235897.49,"total_display":"1,235,897.49","total_whole":"1,235,897","shares_owned_after":17687.0,"shares_owned_after_display":"17,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider","n_lines":5},{"id":2356213,"accession":"0001493152-24-047434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-047434","line_url":"/filing/0001493152-24-047434#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"NEXGEL, INC.","issuer_ticker":"NXGL","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3636.0,"shares_display":"3,636","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":9999.0,"total_display":"9,999.00","total_whole":"9,999","shares_owned_after":106664.0,"shares_owned_after_display":"106,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":3081600,"accession":"0001493152-24-034094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-034094","line_url":"/filing/0001493152-24-034094#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"NEXGEL, INC.","issuer_ticker":"NXGL","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":103028.0,"shares_owned_after_display":"103,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-27","scope":"insider"},{"id":2806354,"accession":"0001415889-24-014552","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-014552","line_url":"/filing/0001415889-24-014552#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":38.24,"price_display":"38.24","price_state":"stated","total_value":764800.0,"total_display":"764,800.00","total_whole":"764,800","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-24","scope":"insider"},{"id":7942730,"accession":"0001493152-23-019457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-019457","line_url":"/filing/0001493152-23-019457#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"NEXGEL, INC.","issuer_ticker":"NXGL","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.3377,"price_display":"2.34","price_state":"stated","total_value":11688.5,"total_display":"11,688.50","total_whole":"11,689","shares_owned_after":93028.0,"shares_owned_after_display":"93,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-26","filed_date":"2023-05-30","scope":"insider"},{"id":6418397,"accession":"0001104659-22-038736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-038736","line_url":"/filing/0001104659-22-038736#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"NEXGEL, INC.","issuer_ticker":"NXGL","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5300.0,"shares_display":"5,300","price_per_share":1.8887,"price_display":"1.89","price_state":"stated","total_value":10010.11,"total_display":"10,010.11","total_whole":"10,010","shares_owned_after":88028.0,"shares_owned_after_display":"88,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-28","scope":"insider"},{"id":6267164,"accession":"0001104659-22-000438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-000438","line_url":"/filing/0001104659-22-000438#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"NEXGEL, INC.","issuer_ticker":"NXGL","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9091.0,"shares_display":"9,091","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":49909.59,"total_display":"49,909.59","total_whole":"49,910","shares_owned_after":82728.0,"shares_owned_after_display":"82,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2022-01-03","scope":"insider"},{"id":4437771,"accession":"0001213900-21-027682","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-027682","line_url":"/filing/0001213900-21-027682#line-2","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":0.9002,"price_display":"0.90","price_state":"stated","total_value":2700.6,"total_display":"2,700.60","total_whole":"2,701","shares_owned_after":22917.0,"shares_owned_after_display":"22,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":4437767,"accession":"0001213900-21-027682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-027682","line_url":"/filing/0001213900-21-027682#line-1","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.888,"price_display":"0.89","price_state":"stated","total_value":2664.0,"total_display":"2,664.00","total_whole":"2,664","shares_owned_after":25917.0,"shares_owned_after_display":"25,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":4883150,"accession":"0001209191-21-012366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012366","line_url":"/filing/0001209191-21-012366#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Officer (Executive VP of Research & Dev)","role_mark":"O","role_mark_label":"Officer (Executive VP of Research & Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP of Research & Dev","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5882.0,"shares_display":"5,882","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":99994.0,"total_display":"99,994.00","total_whole":"99,994","shares_owned_after":5882.0,"shares_owned_after_display":"5,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"},{"id":2651689,"accession":"0001185185-20-000739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001185185-20-000739","line_url":"/filing/0001185185-20-000739#line-1","is_derivative":false,"issuer_cik":"0001433982","issuer_name":"BioSig Technologies, Inc.","issuer_ticker":"BSGM","issuer_name_source":null,"issuer_url":"/issuer/0001433982","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.4889,"price_display":"10.49","price_state":"stated","total_value":10488.9,"total_display":"10,488.90","total_whole":"10,489","shares_owned_after":107944.0,"shares_owned_after_display":"107,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-05-28","scope":"insider"},{"id":8420861,"accession":"0001213900-19-024072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-024072","line_url":"/filing/0001213900-19-024072#line-1","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.925,"price_display":"0.92","price_state":"stated","total_value":1850.0,"total_display":"1,850.00","total_whole":"1,850","shares_owned_after":22917.0,"shares_owned_after_display":"22,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-19","scope":"insider"},{"id":8729731,"accession":"0001213900-19-018664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-018664","line_url":"/filing/0001213900-19-018664#line-1","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":0.935,"price_display":"0.94","price_state":"stated","total_value":3740.0,"total_display":"3,740.00","total_whole":"3,740","shares_owned_after":20917.0,"shares_owned_after_display":"20,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-19","filed_date":"2019-09-23","scope":"insider"},{"id":8300967,"accession":"0001213900-19-006872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-006872","line_url":"/filing/0001213900-19-006872#line-1","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.7274,"price_display":"0.73","price_state":"stated","total_value":7274.0,"total_display":"7,274.00","total_whole":"7,274","shares_owned_after":16917.0,"shares_owned_after_display":"16,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-22","filed_date":"2019-04-22","scope":"insider"},{"id":4879451,"accession":"0001415889-17-000625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-17-000625","line_url":"/filing/0001415889-17-000625#line-1","is_derivative":false,"issuer_cik":"0001404943","issuer_name":"MetaStat, Inc.","issuer_ticker":"MTST.OB","issuer_name_source":null,"issuer_url":"/issuer/0001404943","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-06","scope":"insider"},{"id":4753793,"accession":"0001144204-17-011952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-011952","line_url":"/filing/0001144204-17-011952#line-1","is_derivative":false,"issuer_cik":"0001054274","issuer_name":"Alliqua BioMedical, Inc.","issuer_ticker":"ALQA","issuer_name_source":null,"issuer_url":"/issuer/0001054274","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":686750.0,"shares_owned_after_display":"686,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":5338224,"accession":"0000899243-17-002778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-002778","line_url":"/filing/0000899243-17-002778#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":51500.0,"total_display":"51,500.00","total_whole":"51,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-03","scope":"insider"},{"id":8929158,"accession":"0001213900-15-009681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-15-009681","line_url":"/filing/0001213900-15-009681#line-1","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":3175.0,"total_display":"3,175.00","total_whole":"3,175","shares_owned_after":69166.0,"shares_owned_after_display":"69,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-23","filed_date":"2015-12-23","scope":"insider"},{"id":8843291,"accession":"0001144204-15-063586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-063586","line_url":"/filing/0001144204-15-063586#line-1","is_derivative":false,"issuer_cik":"0001054274","issuer_name":"Alliqua BioMedical, Inc.","issuer_ticker":"ALQA","issuer_name_source":null,"issuer_url":"/issuer/0001054274","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":40740.0,"total_display":"40,740.00","total_whole":"40,740","shares_owned_after":286750.0,"shares_owned_after_display":"286,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-06","filed_date":"2015-11-09","scope":"insider"},{"id":4994931,"accession":"0001354488-13-003762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-003762","line_url":"/filing/0001354488-13-003762#line-1","is_derivative":false,"issuer_cik":"0001054274","issuer_name":"Alliqua, Inc.","issuer_ticker":"ALQA","issuer_name_source":null,"issuer_url":"/issuer/0001054274","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8641975.0,"shares_display":"8,641,975","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":9876543.0,"shares_owned_after_display":"9,876,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-28","filed_date":"2013-07-02","scope":"insider"},{"id":4943582,"accession":"0001213900-13-003308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-13-003308","line_url":"/filing/0001213900-13-003308#line-1","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23809.0,"shares_display":"23,809","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":24999.45,"total_display":"24,999.45","total_whole":"24,999","shares_owned_after":48809.0,"shares_owned_after_display":"48,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-25","filed_date":"2013-06-26","scope":"insider"},{"id":5263095,"accession":"0001354488-13-000857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-000857","line_url":"/filing/0001354488-13-000857#line-1","is_derivative":false,"issuer_cik":"0001054274","issuer_name":"Alliqua, Inc.","issuer_ticker":"ALQA","issuer_name_source":null,"issuer_url":"/issuer/0001054274","owner_cik":"0001433982","owner_name":"ZELDIS JEROME B","owner_display_name":"ZELDIS JEROME B","owner_url":"/insider/0001433982","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1234568.0,"shares_display":"1,234,568","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1234568.0,"shares_owned_after_display":"1,234,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-22","filed_date":"2013-02-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Director","n_filings":2,"first_seen":"2024-05-24","last_seen":"2024-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001468929","name":"NEXGEL, INC.","url":"/issuer/0001468929","role":"Director","n_filings":5,"first_seen":"2022-01-03","last_seen":"2024-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000812796","name":"SOLIGENIX, INC.","url":"/issuer/0000812796","role":"Director","n_filings":6,"first_seen":"2013-06-26","last_seen":"2021-05-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001538210","name":"NexImmune, Inc.","url":"/issuer/0001538210","role":"Officer (Executive VP of Research & Dev)","n_filings":1,"first_seen":"2021-02-19","last_seen":"2021-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001530766","name":"BioSig Technologies, Inc.","url":"/issuer/0001530766","role":"Director","n_filings":1,"first_seen":"2020-05-28","last_seen":"2020-05-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001404943","name":"MetaStat, Inc.","url":"/issuer/0001404943","role":"Director","n_filings":1,"first_seen":"2017-04-06","last_seen":"2017-04-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001054274","name":"Alliqua BioMedical, Inc.","url":"/issuer/0001054274","role":"Director","n_filings":4,"first_seen":"2013-02-25","last_seen":"2017-03-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000850261","name":"Sorrento Therapeutics, Inc.","url":"/issuer/0000850261","role":"Officer","n_filings":1,"first_seen":"2017-02-03","last_seen":"2017-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001433982","retrieved_at":"2026-08-24T20:09:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}